NCT02694354View on ClinicalTrials.gov

Investigation of Single Rising Doses of BI 685509

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

April 30, 2016

Study Completion Date

April 30, 2016

Conditions
Healthy
Interventions
DRUG

BI 685509

DRUG

Placebo

Trial Locations (1)

Unknown

1366.1.1 Boehringer Ingelheim Investigational Site, Biberach

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02694354 - Investigation of Single Rising Doses of BI 685509 | Biotech Hunter | Biotech Hunter